Log in

Relevant bibliographies by topics / Early-stage breast cancer (EBC)

Contents

Journal articles
Dissertations / Theses
Books
Book chapters
Conference papers
Reports

Academic literature on the topic 'Early-stage breast cancer (EBC)'

Author: Grafiati

Published: 2 June 2025

Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Early-stage breast cancer (EBC).'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Early-stage breast cancer (EBC)"

1

Kota, Karthik Joshua, Rekha Gyanchandani, Margaret Quinn Rosenzweig, et al. "cfDNA mutation frequency in early stage breast cancer." Journal of Clinical Oncology 35, no. 15_suppl (2017): e23047-e23047. http://dx.doi.org/10.1200/jco.2017.35.15_suppl.e23047.

Full text

Abstract:

e23047 Background: Though 93% of patient present with early stage breast cancer (EBC), metastatic recurrence is expected in 7-13%. To prevent estrogen receptor (ER) positive disease recurrence, endocrine therapy (ET) is given after local disease. ET guidelines recently extended therapy —specifically tamoxifen—from 5 years to 10 based on ATLAS and aTTom. This pilot study used blood samples from women 6 months post-ET to determine cell free DNA (cfDNA) mutation prevalence in disease-free patients Methods: Patients with EBC and continued follow-up after ET were recruited from the Magee Women’s Br

APA, Harvard, Vancouver, ISO, and other styles

2

Skvortsova, Liliya, Saltanat Abdikerim, Kanagat Yergali, et al. "Association of Genetic Markers with the Risk of Early-Onset Breast Cancer in Kazakh Women." Genes 15, no. 1 (2024): 108. http://dx.doi.org/10.3390/genes15010108.

Full text

Abstract:

Breast cancer is a global health problem. It is an age-dependent disease, but cases of early-onset breast cancer (eBC) are gradually increasing. There are many unresolved questions regarding eBC risk factors, mechanisms of development and screening. Only 10% of eBC cases are due to mutations in the BRCA1/BRCA2 genes, and 90% have a more complex genetic background. This poses a significant challenge to timely cancer detection in young women and highlights the need for research and awareness. Therefore, identifying genetic risk factors for eBC is essential to solving these problems. This study r

APA, Harvard, Vancouver, ISO, and other styles

3

Nelson, David R., Jacqueline Brown, Aki Morikawa, and Michael Method. "Breast cancer-specific mortality in early breast cancer as defined by high-risk clinical and pathologic characteristics." PLOS ONE 17, no. 2 (2022): e0264637. http://dx.doi.org/10.1371/journal.pone.0264637.

Full text

Abstract:

Objectives To investigate breast cancer-specific mortality by early breast cancer (EBC; Stages I-IIIC) subtype; incidence of high-risk indicators for recurrence (defined in monarchE trial); and mortality risk difference by those who did/did not meet these criteria. Materials and methods Analyses included patients with initial EBC diagnosis between 2010–2015 from Surveillance, Epidemiology, and End Results (SEER) data (n = 342,149). Cox proportional hazards models and Kaplan-Meier estimates examined mortality among 228,031 patients, by subtype (hormone receptor [HR]-positive [+], human epiderma

APA, Harvard, Vancouver, ISO, and other styles

4

Hosen, MM Arif, Md Dayem Uddin, Ipshita Zerin, et al. "Evaluation of Skeletal Metastases in Different Clinical Stages of Breast Cancer Patients." TAJ: Journal of Teachers Association 30, no. 2 (2018): 47–53. http://dx.doi.org/10.3329/taj.v30i2.39137.

Full text

Abstract:

Background: Breast cancer is a common form of cancer among women globally. Bone is the most common site to which breast cancer metastasizes. Between 30% and 85% of patients with metastatic breast cancer will develop bone metastases during the course of the disease.Objective: To evaluate the pattern and distribution of skeletal metastases in different clinical stages of breast cancer patients by using Tc-99m MDP bone scan.Materials and methods: A retrospective study was conducted on 305 consecutive female breast carcinoma patients referred for bone scan to Institute of Nuclear Medicine and Alli

APA, Harvard, Vancouver, ISO, and other styles

5

Xi, Jing, Cynthia X. Ma, and Joyce O'Shaughnessy. "Current Clinical Utility of Circulating Tumor DNA Testing in Breast Cancer: A Practical Approach." JCO Oncology Practice 20, no. 11 (2024): 1460–70. http://dx.doi.org/10.1200/op.24.00274.

Full text

Abstract:

Circulating tumor DNA (ctDNA) refers to DNA fragments released from cancer cells into the bloodstream. Clinical utility of ctDNA in breast cancer has been explored in both metastatic breast cancer (MBC) and early-stage breast cancer (EBC) settings. In MBC, ctDNA can detect therapeutically targetable genomic alterations and has shown great potential in predicting treatment response or resistance. Accumulating data suggest that ctDNA might also have prognostic value in MBC. In EBC, emerging data have shown ctDNA's predictive and/or prognostic value in both neoadjuvant and adjuvant settings. Mini

APA, Harvard, Vancouver, ISO, and other styles

6

Gion, María, José Manuel Pérez-García, Antonio Llombart-Cussac, Miguel Sampayo-Cordero, Javier Cortés, and Andrea Malfettone. "Surrogate endpoints for early-stage breast cancer: a review of the state of the art, controversies, and future prospects." Therapeutic Advances in Medical Oncology 13 (January 2021): 175883592110595. http://dx.doi.org/10.1177/17588359211059587.

Full text

Abstract:

Drug approval for early-stage breast cancer (EBC) has been historically granted in the context of registration trials based on adequate outcomes such as disease-free survival and overall survival. Improvements in long-term outcomes have made it more difficult to demonstrate the clinical benefit of a new cancer drug in large, randomized, comparative clinical trials. Therefore, the use of surrogate endpoints rather than traditional measures allows for cancer drug trials to proceed with smaller sample sizes and shorter follow-up periods, which reduces drug development time. Among surrogate endpoi

APA, Harvard, Vancouver, ISO, and other styles

7

Franks, Jeffrey, Risha Gidwani, Ene Mercy Enogela, et al. "Survival in the real world: A national analysis of patients treated for early-stage breast cancer." Journal of Clinical Oncology 39, no. 28_suppl (2021): 75. http://dx.doi.org/10.1200/jco.2020.39.28_suppl.75.

Full text

Abstract:

75 Background: Many patient population groups are not proportionally represented in clinical trials, including patients of color, at age extremes, or with comorbidities. It is unclear how treatment outcomes may differ for these patients compared to those well represented in trials. Methods: This retrospective cohort study included women diagnosed with early-stage (I-III) breast cancer (EBC) between 2005-2015 in the CancerLinQ Discovery electronic medical record-based dataset. Patients with comorbidities or concurrent cancer were considered unrepresented in clinical trials. Non-White patients a

APA, Harvard, Vancouver, ISO, and other styles

8

Powis, Melanie, Alejandro Gonzalez, Rinku Sutradhar, et al. "Establishing achievable benchmarks for quality improvement in systemic therapy for early-stage breast cancer." Journal of Clinical Oncology 34, no. 7_suppl (2016): 263. http://dx.doi.org/10.1200/jco.2016.34.7_suppl.263.

Full text

Abstract:

263 Background: Setting realistic targets for performance on quality indicators (QI) is a consistent challenge in quality improvement. The purpose of this study was to utilize administrative data to define achievable targets for QI in the early stage breast cancer (EBC) population in relation to systemic therapy (ST) delivery based on best performers. Methods: Deterministically linked administrative healthcare databases were used to identify EBC cases diagnosed 2006 – 2010 in Ontario, Canada. Panel of previously established QIs for systemic therapy was applied to patients who met eligibility c

APA, Harvard, Vancouver, ISO, and other styles

9

Abdel-Qadir, Husam, Paaladinesh Thavendiranathan, Peter C. Austin, et al. "The Risk of Heart Failure and Other Cardiovascular Hospitalizations After Early Stage Breast Cancer: A Matched Cohort Study." JNCI: Journal of the National Cancer Institute 111, no. 8 (2019): 854–62. http://dx.doi.org/10.1093/jnci/djy218.

Full text

Abstract:

AbstractBackgroundData are limited regarding the risk of heart failure (HF) requiring hospital-based care after early stage breast cancer (EBC) and its relationship to other types of cardiovascular disease (CVD).MethodsWe conducted a population-based, retrospective cohort study of EBC patients (diagnosed April 1, 2005–March 31, 2015) matched 1:3 on birth-year to cancer-free control subjects. We identified hospitalizations and emergency department visits for CVD through March 31, 2017. We used cumulative incidence function curves to estimate CVD incidence and cause-specific regression models to

APA, Harvard, Vancouver, ISO, and other styles

10

Fedele, Palma, Assunta Maria Lapolla, Laura Orlando, et al. "Analysis of correlation between weight at diagnosis, weight gain after breast cancer treatment, and recurrence in women with early-stage breast cancer (EBC)." Journal of Clinical Oncology 30, no. 15_suppl (2012): e11001-e11001. http://dx.doi.org/10.1200/jco.2012.30.15_suppl.e11001.

Full text

Abstract:

e11001 Background: Overweight at the time of EBC diagnosis has been linked frequently to poorer survival in most studies and some evidence suggests that women who gain weight after breast cancer diagnosis are at increased risk of cancer recurrence and death. Most previous studies on this topic have relied on retrospective chart reviews. The aim of this prospective, observational, single-center study is to determine whether weight at diagnosis and weight gain after EBC treatment can be predictive of BC recurrence. Methods: From December 1990 to January 2012, the study included atotal of 311 EBC

APA, Harvard, Vancouver, ISO, and other styles

More sources

Dissertations / Theses on the topic "Early-stage breast cancer (EBC)"

1

Brazel, Sandra Lynn. "Resting metabolic rate in women with early stage breast cancer." Thesis, National Library of Canada = Bibliothèque nationale du Canada, 1997. http://www.collectionscanada.ca/obj/s4/f2/dsk2/ftp01/MQ29293.pdf.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Khoshaba, Ramina. "PROMOTING ROLE OF AKR1B10 IN HER2+ BREAST CANCER AT EARLY STAGE." OpenSIUC, 2019. https://opensiuc.lib.siu.edu/dissertations/1678.

Full text

Abstract:

Breast cancer is the most common type of cancer diagnosed among women in the United States, and the second cause of female cancer-related death, with approximately 40,000 deaths annually. Aldo-keto reductase 1B10 (AKR1B10) is a 35-kDa protein that is highly expressed in breast cancer in infiltrative and Ductal Carcinoma in Situ (DCIS) stages. Recent studies have demonstrated that AKR1B10 promotes breast cancer cell adhesion and invasion through the expression of integrin α5 and δ-catenin. Human epidermal growth factor receptor2 (HER2) is a tyrosine kinase receptor which is over expressed in ov

APA, Harvard, Vancouver, ISO, and other styles

3

Scullard, Nicole. "Subjective lived experiences of women with early stage breast cancer in Cape Town." University of the Western Cape, 2015. http://hdl.handle.net/11394/5081.

Full text

Abstract:

Magister Artium - MA<br>Breast cancer is a common cause of death among women worldwide. It has long been recognized as a major public health burden in high-income countries, however, the majority of cases are said to occur in low and middle-income countries, such as in South Africa. A breast cancer diagnosis and treatment heralds a series of frightening events and can be a traumatic experience. The manner in which women perceive and cope with their illness is predictive of emotional and physical health outcomes. It is thus imperative to explore the experiences of South African women, whose voi

APA, Harvard, Vancouver, ISO, and other styles

4

Bennett, Barbara Kaye School of Medicine UNSW. "Characterising the nature of postcancer fatigue in women treated for early-stage breast cancer." Awarded by:University of New South Wales. School of Medicine, 2006. http://handle.unsw.edu.au/1959.4/31202.

Full text

Abstract:

The problem investigated Four studies investigated the phenomenon of cancer-related fatigue (CRF) in women who had received adjuvant treatment for early-stage breast cancer, with a view to reducing the diagnostic uncertainty surrounding the syndrome and thus facilitating progress in both clinical management and aetiological research. Procedures and results A cross-sectional study of 109 women compared a ???cancer-specific??? self-report questionnaire (FACT-F) (canvassing fatigue symptoms) and a more generic questionnaire (SPHERE) (identifying depression and fatigue). Thirty-seven percent of wo

APA, Harvard, Vancouver, ISO, and other styles

5

Elele, Tugba. "A Decision Analytic Model For Early Stage Breast Cancer Patients: Lumpectomy Vs Mastectomy." Master's thesis, METU, 2006. http://etd.lib.metu.edu.tr/upload/12607770/index.pdf.

Full text

Abstract:

The purpose of this study was to develop a decision model for early-stage breast cancer patients. This model provides an opportunity for comparing two main treatment options, mastectomy and lumpectomy, with respect to quality of life by making use of Decision Theoretic Techniques. A Markov chain was constructed to project the clinical history of breast carcinoma following surgery. Then, health states used in the model were characterized by transition probabilities and utilities for quality of life. A Multi Attribute Utility Model was developed for outcome evaluation. This study was performed

APA, Harvard, Vancouver, ISO, and other styles

6

Yackzan, Susan G. "FACTORS INFLUENCING PREFERENCE FOR SURGICAL CHOICE AMONG WOMEN WITH EARLY STAGE BREAST CANCER." UKnowledge, 2017. https://uknowledge.uky.edu/nursing_etds/34.

Full text

Abstract:

Breast cancer is the most common cancer among women in the United States with over 60% of cases diagnosed as early stage disease. For those women without prohibiting clinical or cosmetic concerns, a choice between breast-conserving surgery and mastectomy can be made. Either choice confers equivalent survival. The decision-making process also involves consideration of recurrence risk as well as management of the unaffected, contralateral breast for both future surveillance and risk reduction. In recent years, increasing rates of mastectomy with contralateral prophylactic mastectomy have been re

APA, Harvard, Vancouver, ISO, and other styles

7

Glangkarn, Sumattana. "Quality of life in Thai women with early-stage breast cancer during adjuvant treatment." Thesis, University of Nottingham, 2009. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.523086.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Johnston, Elaine. "Psychological impact of diagnosis and surgery in the treatment of early stage breast cancer." Thesis, University of Edinburgh, 2001. http://hdl.handle.net/1842/29822.

Full text

Abstract:

Comparable effectiveness of breast conserving therapy (BCT) with mastectomy for early stage breast cancer has now been demonstrated (Early Breast Trialists' Collaborative Group, 1995). The widespread introduction of BCT was expected to significantly improve the quality of life for many women (Fallowfield & Clark, 1992). However, studies comparing the psychosocial outcome of BCT with mastectomy have failed to demonstrate any evidence of substantial benefit for BCT in relation to aspects of quality of life other than body image, with levels of psychological distress as frequent for patients in b

APA, Harvard, Vancouver, ISO, and other styles

9

Kamanga, Thembekile Nokukhanya. "A microsociological analysis of social support to women diagnosed with early stage breast cancer." Thesis, University of the Western Cape, 2016. http://hdl.handle.net/11394/5536.

Full text

Abstract:

Magister Artium - MA<br>This study explored the social support provided by family of women diagnosed with early stage breast cancer. The aim was to present an account of social support that is solicited by and given to women diagnosed with early stage breast cancer. There is a dearth amount of literature on support from families of women with breast cancer in South Africa. Thus, this study can potentially contribute to filling the gap of knowledge in this area in the country. Qualitative method was used and in-depth interviews were utilized to study the women's experience of family social supp

APA, Harvard, Vancouver, ISO, and other styles

10

Di, Meglio Antonio. "Health Behaviors and Breast Cancer Survivorship Body Weight and Return to Work Among Survivors of Early-Stage Breast Cancer. Changes in Weight, Physical and Psychosocial Patient-Reported Outcomes Among Obese Women Receiving Treatment for Early-Stage Breast Cancer: A Nationwide Clinical Study." Thesis, université Paris-Saclay, 2020. http://www.theses.fr/2020UPASL059.

Full text

Abstract:

Les survivantes du cancer du sein (CS) de stade précoce ont souvent un impact considérable et persistant des symptômes liées aux traitements. Cette thèse rassemble plusieurs projets exploitant les données de l'étude CANcer TOxicity (CANTO; NCT01993498) pour comprendre le potentiel des comportements de santé (CSAN), notamment le maintien d'un indice de masse corporelle (IMC) sain, le respect des recommandations en matière d'activité physique (AP), l'arrêt du tabac et la limitation de la consommation d'alcool, pour préserver la qualité de vie (QV) chez les survivantes du CS. CANTO est une cohort

APA, Harvard, Vancouver, ISO, and other styles

More sources

Books on the topic "Early-stage breast cancer (EBC)"

1

Kunheri, Beena, and D. K. Vijaykumar, eds. Management of Early Stage Breast Cancer. Springer Singapore, 2021. http://dx.doi.org/10.1007/978-981-15-6171-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Illy, Judith. The management of early breast cancer: Non-infiltrative stage I and stage II disease. U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health, National Cancer Institute, International Cancer Research Data Bank, 1990.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

3

Kinoshita, Takayuki, ed. Non-surgical Ablation Therapy for Early-stage Breast Cancer. Springer Japan, 2016. http://dx.doi.org/10.1007/978-4-431-54463-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Shockney, Lillie. Top concerns about breast cancer: Early stage and beyond. Jones & Bartlett Learning, 2011.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

5

National Cancer Institute (U.S.), ed. Radiation therapy: A treatment for early stage breast cancer. U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health, National Cancer Institute, 1990.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

6

Brazel, Sandra Lynn. Resting metabolic rate in women with early stage breast cancer. National Library of Canada = Bibliothèque nationale du Canada, 1999.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

7

National Cancer Institute (U.S.). Office of Cancer Communications, ed. Primary treatment is not enough for early stage breast cancer. 2nd ed. National Cancer Institute, Office of Cancer Communications, 1988.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

8

Younis, Tallal. Wait times in the management of early stage breast cancer. Nova Science, 2011.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

9

Miller, Naomi. Treatment of early-stage breast cancer: January 1985 through May 1990 : 668 citations. U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health, National Library of Medicine, Reference Section ; Washington, D.C. : Sold by the Supt. of Docs., U.S. G.P.O., 1990.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

10

Miller, Naomi. Treatment of early-stage breast cancer: January 1985 through May 1990 : 668 citations. U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health, National Library of Medicine, Reference Section ; Washington, D.C. : Sold by the Supt. of Docs., U.S. G.P.O., 1990.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

More sources

Book chapters on the topic "Early-stage breast cancer (EBC)"

1

Arslan Ibis, Kamuran, Makbule Tambas, and Seden Kucucuk. "Early-Stage Breast Cancer Radiotherapy." In Breast Cancer. Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-96947-3_19.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Dragun, Anthony E., Paul J. Schilling, Tod W. Speer, et al. "Early-Stage Breast Cancer." In Encyclopedia of Radiation Oncology. Springer Berlin Heidelberg, 2013. http://dx.doi.org/10.1007/978-3-540-85516-3_85.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Dincer, Maktav. "Early Stage Breast Cancer." In Principles and Practice of Modern Radiotherapy Techniques in Breast Cancer. Springer New York, 2012. http://dx.doi.org/10.1007/978-1-4614-5116-7_9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Ozer, Leyla, and Adnan Aydiner. "Adjuvant Chemotherapy for HER2-Negative Early-Stage Breast Cancer." In Breast Cancer. Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-96947-3_15.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Bayraktar, Soley, and Adnan Aydiner. "Adjuvant Therapy for HER2-Positive Early-Stage Breast Cancer." In Breast Cancer. Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-96947-3_16.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Ozmen, Vahit. "Surgical Treatment of Early-Stage Breast Cancer." In Breast Disease. Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-26012-9_4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Ozmen, Vahit, and Volkan Dogru. "Surgical Treatment of Early-Stage Breast Cancer." In Breast Disease. Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-16792-9_4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Vezeridis, Michael P., and Kirby I. Bland. "Surgical and Medical Management of In Situ and Early Stage Breast Carcinoma." In Breast Cancer. Springer New York, 1999. http://dx.doi.org/10.1007/978-1-4612-2146-3_9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Nambiar, Ajith. "Pathology of Early Breast Carcinomas." In Management of Early Stage Breast Cancer. Springer Singapore, 2020. http://dx.doi.org/10.1007/978-981-15-6171-9_4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Gul, Hira, Iqra, and Nosheen Masood. "Early-Stage Progression of Breast Cancer." In Breast Cancer: From Bench to Personalized Medicine. Springer Nature Singapore, 2022. http://dx.doi.org/10.1007/978-981-19-0197-3_6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Early-stage breast cancer (EBC)"

1

Zardari, Shehnila, Nisar Ahmed Shar, Maria Munawwar, Ume-Hani Usman, Zeba Shabbir, and Mahrukh Khan. "Early Stage Breast Cancer Prediction Using Image Processing." In 2024 4th International Conference on Innovations in Computer Science (ICONICS). IEEE, 2024. https://doi.org/10.1109/iconics64289.2024.10824624.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Vandana, CP, M. Shivani Kashyap, D. Yashas, and Neha Singh. "Exploratory Analysis of Heart Attack and Breast Cancer Early Stage Prediction." In 2024 Third International Conference on Trends in Electrical, Electronics, and Computer Engineering (TEECCON). IEEE, 2024. https://doi.org/10.1109/teeccon64024.2024.10941411.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Teles, Ludmila Thommen, Vitor Heidrich, Rosângela Vieira de Andrade, et al. "Enrichment of intestinal bifidobacterium genus is associated with residual disease among patients with early-stage HER2+ breast cancer (BC) following neoadjuvant chemotherapy (NACT)." In Brazilian Breast Cancer Symposium 2024. Mastology, 2024. http://dx.doi.org/10.29289/259453942024v34s1016.

Full text

Abstract:

Objective: The objective of this study was to characterize the gut microbiome (GM) of patients with early-stage breast cancer (eBC) who underwent NACT and to evaluate its association with clinicopathological factors and outcomes. Methodology: This was a prospective study conducted at two Brazilian Institutions. Fecal samples were collected at the baseline and prior to surgery. The GM was analyzed by 16S rRNA amplicon sequencing to characterize the alpha (InvSimpson indexes) and beta (weighted UniFrac distance) diversity, as well as the taxonomic composition. Results: Among the 55 female patien

APA, Harvard, Vancouver, ISO, and other styles

4

Couto, Henrique Lima, Bertha Andrade Coelho, Bernardo Ferreira de Paula Ricardo, et al. "Vacuum-assisted excision: a single-step approach to the diagnosis and treatment of early breast cancers – initial report." In Brazilian Breast Cancer Symposium 2024. Mastology, 2024. http://dx.doi.org/10.29289/259453942024v34s1006.

Full text

Abstract:

Objective: The aim of this study was to describe the initial experience applying vacuum-assisted excision (VAE) associated with cavity margins sampling shaving (CMSH) to breast lesions (BL), smaller than 15 mm and suspected of malignancy, as a single-step approach in diagnosing and treating early breast cancers (EBC). Methodology: An open interventional study was conducted recruiting patients with Category 4 and 5 ACR BI-RADS™ BL, smaller than 15 mm, candidates for VAE. Patients with diagnosed multifocal/multicentric breast cancer (BC) were excluded. The VAE was performed, complete BL excision

APA, Harvard, Vancouver, ISO, and other styles

5

Yariv, Orly, Rinat Yerushalmi, Assaf Moore, et al. "Abstract PS8-21: The impact of exogenous estrogen exposure on the characteristics of estrogen receptor (ER) positive, early-stage breast cancer (EBC)." In Abstracts: 2020 San Antonio Breast Cancer Virtual Symposium; December 8-11, 2020; San Antonio, Texas. American Association for Cancer Research, 2021. http://dx.doi.org/10.1158/1538-7445.sabcs20-ps8-21.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Lux, MP, A. Benedict, S. Buchholz, et al. "Cost-effectiveness of anastrozole versus tamoxifen as adjuvant therapy in early breast cancer (EBC) – a German health economic analysis." In CTRC-AACR San Antonio Breast Cancer Symposium: 2008 Abstracts. American Association for Cancer Research, 2009. http://dx.doi.org/10.1158/0008-5472.sabcs-6109.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Argyriadis, A., K. Kalfoutzos, S. Khodaverdi, S. Braun, and C. Jackisch. "Resistance to HER2 targeted therapy in early breast cancer (EBC): The clinical management of intratumoral heterogeneity (ITH) in HER2 overexpressing EBC." In 64. Kongress der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe e. V. Georg Thieme Verlag, 2022. http://dx.doi.org/10.1055/s-0042-1756741.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Poole, C., C. Barrios, J. O'Shaughnessy, M. Martin, and V. Möbus. "Abstract P5-10-11: Ongoing Evaluation of Capecitabine-Based Therapy in Early Breast Cancer (EBC)." In Abstracts: Thirty-Third Annual CTRC‐AACR San Antonio Breast Cancer Symposium‐‐ Dec 8‐12, 2010; San Antonio, TX. American Association for Cancer Research, 2010. http://dx.doi.org/10.1158/0008-5472.sabcs10-p5-10-11.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

De Laurentiis, M., C. Criscitiello, A. Giordano, et al. "HER2status and efficay of taxane-based adjuvant therapy of early breast cancer (EBC): a metanalysis of randomized trials involving 7,831 patients." In CTRC-AACR San Antonio Breast Cancer Symposium: 2008 Abstracts. American Association for Cancer Research, 2009. http://dx.doi.org/10.1158/0008-5472.sabcs-707.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Esteva, FJ, HC Chung, ME Royce, SY Lee, SJ Lee, and J. Stebbing. "Abstract P5-20-14: Cardiotoxicity in 1 year of treatment with reference trastuzumab and its biosimilar candidate CT-P6 in HER2 positive early stage breast cancer (EBC) patients." In Abstracts: 2017 San Antonio Breast Cancer Symposium; December 5-9, 2017; San Antonio, Texas. American Association for Cancer Research, 2018. http://dx.doi.org/10.1158/1538-7445.sabcs17-p5-20-14.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Early-stage breast cancer (EBC)"

1

Lahann, Joerg. Development of a Smart Diagnostics Platform for Early-Stage Screening of Breast Cancer. Defense Technical Information Center, 2007. http://dx.doi.org/10.21236/ada485476.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Lahann, Joerg. Development of a Smart Diagnostics Platform for Early-Stage Screening of Breast Cancer. Defense Technical Information Center, 2007. http://dx.doi.org/10.21236/ada471011.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Shumway, Dean A., Kimberly S. Corbin, Magdoleen H. Farah, et al. Partial Breast Irradiation for Breast Cancer. Agency for Healthcare Research and Quality (AHRQ), 2023. http://dx.doi.org/10.23970/ahrqepccer259.

Full text

Abstract:

Objectives. To evaluate the comparative effectiveness and harms of partial breast irradiation (PBI) compared with whole breast irradiation (WBI) for early-stage breast cancer, and how differences in effectiveness and harms may be influenced by patient, tumor, and treatment factors, including treatment modality, target volume, dose, and fractionation. We also evaluated the relative financial toxicity of PBI versus WBI. Data sources. MEDLINE®, Embase®, Cochrane Central Registrar of Controlled Trials, Cochrane Database of Systematic Reviews, Scopus, and various grey literature sources from databa

APA, Harvard, Vancouver, ISO, and other styles

4

Marcom, Paul K. Utilization of Genomic Signatures to Direct Use of Primary Chemotherapy in Early Stage Breast Cancer. Defense Technical Information Center, 2012. http://dx.doi.org/10.21236/ada569023.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Li, Tong, Erin Mathieu, Michelle Dickson, and Nehmat Houssami. Evidence relevant to early detection of breast cancer in Aboriginal and Torres Strait Islander women. The Sax Institute, 2021. http://dx.doi.org/10.57022/plnx1508.

Full text

Abstract:

This Evidence Snapshot aims to summarise the current and emerging evidence regarding early detection of breast cancer in Aboriginal and Torres Strait Islander women and its impact on cancer stage at diagnosis and mortality. Gaps were found in the evidence regarding impact, but evidence was found regarding incidence, participation, and mortality. Aboriginal and Torres Strait Islander women over 60 were found to have higher incidence of breast cancer than non-indigenous women, and overall Aboriginal and Torres Strait Islander women were found to have lower screening participation rates. Regardin

APA, Harvard, Vancouver, ISO, and other styles

6

Feng, Jiang-yi, Ge Li, Yi Guo, Yun-han Gao, and Sha-ying Ma. Effectiveness of intraoperative radiotherapy versus hypofractionated postmastectomy radiotherapy for early stage breast cancer: A protocol for systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2020. http://dx.doi.org/10.37766/inplasy2020.11.0115.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Liu, Jiaxin, Xiaowei Shi, Yi Zhang, and Jiabao Zhang. Efficacy comparison of intraoperative radiotherapy and external boost irradiation therapy for early-stage breast cancer: a systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2023. http://dx.doi.org/10.37766/inplasy2023.5.0025.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Li, Tian, and Min Sun. Intraoperative radiotherapy is not a better alternative to whole breast radiotherapy as a therapeutic option for early stage breast cancer: a pooling analysis of randomized controlled trials. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2020. http://dx.doi.org/10.37766/inplasy2020.12.0008.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Liang, Yu-Qin, Sen-Quan Feng, Wen-Jia Xie, and Liang-Xi Xie. Efficacy and safety evaluation of radiotherapy options after lumpectomy for early-stage breast cancer: a systematic review and network meta-analysis of randomized clinical trials. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2021. http://dx.doi.org/10.37766/inplasy2021.8.0093.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Rankin, Nicole, Deborah McGregor, Candice Donnelly, et al. Lung cancer screening using low-dose computed tomography for high risk populations: Investigating effectiveness and screening program implementation considerations: An Evidence Check rapid review brokered by the Sax Institute (www.saxinstitute.org.au) for the Cancer Institute NSW. The Sax Institute, 2019. http://dx.doi.org/10.57022/clzt5093.

Full text

Abstract:

Background Lung cancer is the number one cause of cancer death worldwide.(1) It is the fifth most commonly diagnosed cancer in Australia (12,741 cases diagnosed in 2018) and the leading cause of cancer death.(2) The number of years of potential life lost to lung cancer in Australia is estimated to be 58,450, similar to that of colorectal and breast cancer combined.(3) While tobacco control strategies are most effective for disease prevention in the general population, early detection via low dose computed tomography (LDCT) screening in high-risk populations is a viable option for detecting asy

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!